Management of Chest Pain in Elderly Patients on Anticoagulation

Initial Assessment and Risk Stratification

• The American Heart Association suggests that a patient's advanced age and response to nitroglycerin warrant urgent evaluation for possible acute coronary syndrome (ACS), despite the limitations of nitroglycerin response as a diagnostic tool 1

Antiplatelet Considerations

• The American College of Cardiology recommends against adding aspirin to existing anticoagulation therapy in patients of advanced age (≥65 years) due to a substantial increase in the risk of bleeding complications, particularly in those on apixaban 2, 3
• In patients ≥65 years who are already on anticoagulation, such as apixaban, the addition of aspirin is rated as "inappropriate" due to bleeding risk, with a strength of evidence considered high 3

Management Algorithm

• The American Heart Association advises against administering aspirin 325mg to a patient already on apixaban due to the high bleeding risk, especially in elderly patients 4, 2, 3
• For a high-risk patient with chest pain responding to nitroglycerin, emergency medical services should be activated immediately, with rapid transport to an emergency department with cardiac capabilities 1, 5
• Nitroglycerin can be repeated every 5 minutes for a maximum of 3 doses if symptoms persist, as recommended by the American College of Cardiology 6
• An ECG should be performed and evaluated within 10 minutes of arrival, according to the American Heart Association guidelines 1

Management of Anticoagulation and Antiplatelet Therapy in Elderly Patients with Chest Pain

Rationale for Avoiding Aspirin in Elderly Patients on Anticoagulation

• The combination of antiplatelet therapy with anticoagulants significantly increases bleeding risk, which is especially concerning in very elderly patients (94 years old) 7

Management Algorithm for Chest Pain in Elderly Patients on Anticoagulation

Initial Assessment

• Perform 12-lead ECG within 10 minutes of arrival to evaluate for acute coronary syndrome (ACS) 8
• Obtain cardiac biomarkers to assess for myocardial injury 8

Anticoagulation Management

• If coronary intervention becomes necessary, decisions about antithrombotic therapy should be made by the cardiology team based on the specific findings 7

Symptomatic Management

• Nitroglycerin can be repeated every 5 minutes for a maximum of 3 doses if symptoms persist 8, 9
• Consider morphine for pain relief if nitroglycerin is insufficient 10
• Administer oxygen if hypoxemia, breathlessness, or signs of heart failure are present 10

Clinical Considerations and Pitfalls

• Guidelines consistently prioritize bleeding risk assessment in elderly patients on anticoagulation when considering additional antithrombotic therapy 7